Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.
Ann Oncol. 2018 Oct 1;29(10):2098-2104. doi: 10.1093/annonc/mdy329.
Ann Oncol. 2018.
PMID: 30412222
Free PMC article.
Clinical Trial.
Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma.
Porta C, Gore ME, Rini BI, Escudier B, Hariharan S, Charles LP, Yang L, DeAnnuntis L, Motzer RJ.
Porta C, et al. Among authors: deannuntis l.
Eur Urol. 2016 Feb;69(2):345-51. doi: 10.1016/j.eururo.2015.07.006. Epub 2015 Jul 26.
Eur Urol. 2016.
PMID: 26215605
Free PMC article.
Item in Clipboard
Long-Term Safety With Axitinib in Previously Treated Patients With Metastatic Renal Cell Carcinoma.
Rini BI, Escudier B, Hariharan S, Roberts WG, Tarazi J, Rosbrook B, Askerova Z, DeAnnuntis LL, Motzer RJ.
Rini BI, et al. Among authors: deannuntis ll.
Clin Genitourin Cancer. 2015 Dec;13(6):540-7.e1-7. doi: 10.1016/j.clgc.2015.07.001. Epub 2015 Jul 20.
Clin Genitourin Cancer. 2015.
PMID: 26320662
Clinical Trial.
Item in Clipboard
Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.
Hurvitz SA, Gonçalves A, Rugo HS, Lee KH, Fehrenbacher L, Mina LA, Diab S, Blum JL, Chakrabarti J, Elmeliegy M, DeAnnuntis L, Gauthier E, Czibere A, Tudor IC, Quek RGW, Litton JK, Ettl J.
Hurvitz SA, et al. Among authors: deannuntis l.
Oncologist. 2020 Mar;25(3):e439-e450. doi: 10.1634/theoncologist.2019-0493. Epub 2019 Nov 25.
Oncologist. 2020.
PMID: 32162822
Free PMC article.
Clinical Trial.
Item in Clipboard
Item in Clipboard
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.
Mehra N, Fizazi K, de Bono JS, Barthélémy P, Dorff T, Stirling A, Machiels JP, Bimbatti D, Kilari D, Dumez H, Buttigliero C, van Oort IM, Castro E, Chen HC, Di Santo N, DeAnnuntis L, Healy CG, Scagliotti GV.
Mehra N, et al. Among authors: deannuntis l.
Oncologist. 2022 Oct 1;27(10):e783-e795. doi: 10.1093/oncolo/oyac172.
Oncologist. 2022.
PMID: 36124924
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study.
Gambacorti-Passerini C, Cortes JE, Lipton JH, Kantarjian HM, Kim DW, Schafhausen P, Crescenzo R, Bardy-Bouxin N, Shapiro M, Noonan K, Leip E, DeAnnuntis L, Brümmendorf TH, Khoury HJ.
Gambacorti-Passerini C, et al. Among authors: deannuntis l.
Haematologica. 2018 Aug;103(8):1298-1307. doi: 10.3324/haematol.2017.171249. Epub 2018 May 17.
Haematologica. 2018.
PMID: 29773593
Free PMC article.
Clinical Trial.
Item in Clipboard
Pregnancy outcomes in patients treated with bosutinib.
Cortes JE, Gambacorti-Passerini C, Deininger M, Abruzzese E, DeAnnuntis L, Brümmendorf TH.
Cortes JE, et al. Among authors: deannuntis l.
Int J Hematol Oncol. 2020 May 29;9(2):IJH26. doi: 10.2217/ijh-2020-0004.
Int J Hematol Oncol. 2020.
PMID: 33005329
Free PMC article.
Item in Clipboard
Cite
Cite